Marshall Islands vs Mongolia: The number of people with susceptibility test result for rifampicin
Marshall Islands
100
in 2021
Mongolia
100
in 2021
Marshall Islands rank
2nd
Mongolia rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Marshall Islands
- Mongolia
How they compare
Marshall Islands currently reports 100 against 100 in Mongolia, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Marshall Islands ahead.
Marshall Islands ranks 2nd and Mongolia ranks 2nd of 146 countries.
Across the 2 decades both report, Marshall Islands averaged higher in 1 and Mongolia in 1.
Head to head by decade
| Decade | Marshall Islands | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.97 | 74.64 | 22.33 | Marshall Islands |
| 2020s | 87.04 | 100 | 12.96 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Marshall Islands or Mongolia?
- Marshall Islands, at 100 against 100 in Mongolia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Marshall Islands and Mongolia?
- 0, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Mongolia?
- 5 years are reported by both, from 2017 to 2021.
- How do Marshall Islands and Mongolia rank globally for the number of people with susceptibility test result for rifampicin?
- Marshall Islands ranks 2nd and Mongolia ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.